| Literature DB >> 29162121 |
Ozge Kenis-Coskun1, Evrim Karadag-Saygi2, Yeliz Bahar-Ozdemir2, Yasemin Gokdemir3, Bulent Karadag3, Onder Kayhan2.
Abstract
BACKGROUND: Cystic fibrosis (CF) affects the musculoskeletal system via a multifactorial pathway that includes vitamin D deficiency and involvement of respiratory muscles such as intercostals due to recurrent upper and lower respiratory tract infections. Eventual result is the deterioration of musculoskeletal health and posture in CF patients. Postural stability is directly affected by posture and can be compromised in every musculoskeletal problem. The aim of this study is to evaluate musculoskeletal system and postural stability in patients with CF.Entities:
Keywords: Cystic fibrosis; Musculoskeletal system; Postural stability; Posture; Spine
Mesh:
Year: 2017 PMID: 29162121 PMCID: PMC5696729 DOI: 10.1186/s13052-017-0426-0
Source DB: PubMed Journal: Ital J Pediatr ISSN: 1720-8424 Impact factor: 2.638
Fig. 1Patient enrollment process of the study
Demographic properties of the patients with CF
| Minimum | Maximum | Mean | Std. Deviation | |
|---|---|---|---|---|
| Age (years) | 6 | 28 | 14.04 | 5.344 |
| FEV1 (%) | 35 | 118 | 77.70 | 20.420 |
| FVC | 47 | 118 | 80.9 | 17.4 |
| FEV1/FVC (%) | 61 | 115 | 98.5 | 12.2 |
| Vitamin D level (ng/ml) | 3.00 | 47.15 | 17.86 | 9.56 |
| BMI z scores | −3.30 | 1.46 | −.69 | 1.18 |
| Treatment Duration (years) | 1 | 25 | 11.30 | 5.72 |
Characteristics of the control group
| CF | Control |
| |
|---|---|---|---|
| Age mean SD (min-max) | 14.04 5.34 (6–28) | 12.48 4.1 (7–24) | 0.80 |
| Gender | female 25 | female 42 | 0.61 |
| male 26 | male 53 | ||
| BMI mean SD (min-max) | 18.56 3.41 (13.01–26.51) | 19.10 3.8 (13.1–25.61) | 0.72 |
Answers to the scanning questions in pGALS
| CF group | Control group |
| ||
|---|---|---|---|---|
| Are there any pain or stiffness in your joints? | Yes | 15 | 30 | 0.775 |
| No | 25 | 56 | ||
| Can you dress on your own? | Yes | 45 | 86 | 0.634 |
| No | 0 | 0 | ||
| Do you experience difficulty going up and down the stairs? | Yes | 15 | 3 | <0.0001 |
| No | 30 | 78 |
Results of pGALS examination
| CF group | Control Group |
| ||
|---|---|---|---|---|
| Lower extremity- Appearance | Normal | 37 | 76 | 0.006* |
| Pathological | 8 | 5 | ||
| Lower extremity- Movement | Normal | 41 | 81 | 0.015* |
| Pathological | 4 | 0 | ||
| Spine -Appearance | Normal | 29 | 72 | 0.001* |
| Pathological | 16 | 9 | ||
| Spine- Movement | Normal | 40 | 80 | 0.022* |
| Pathological | 5 | 1 | ||
| Gait -appearance | Normal | 35 | 76 | 0.008* |
| Pathological | 10 | 5 | ||
| Gait- movement | Normal | 40 | 81 | 0.005* |
| Pathological | 5 | 0 |
*shows the presence of significant difference
Significant differences in postural stability tests between groups summarized. Student’s t-test or Mann-Whitney-U test were used according to the distribution of the data
| CF group Mean ± Std Dev | Control group Mean ± Std Dev |
| |
|---|---|---|---|
| Tandem walking speed | 20.47 ± 6.95 | 24.45 ± 7.79 | 0.030 |
| MVL 3 | 5.73 ± 2.43 | 7.12 ± 4.88 | 0.030 |
| MVL 6 | 4.90 ± 3.18 | 5.74 ± 2.52 | 0.050 |
| EPE 1 | 63.22 ± 28.68 | 71.57 ± 25.73 | 0.026 |
| EPE 7 | 83.89 ± 22.39 | 90.18 ± 26.89 | 0.027 |
| DC 1 | 70.32 ± 29.39 | 78.01 ± 23.10 | 0.050 |
| DC 2 | 67.62 ± 24.69 | 74.68 ± 18.58 | 0.050 |
| DC 8 | 57.94 ± 31.30 | 70.41 ± 22.93 | 0.010 |
MVL Movement velocity, EPE end point excursion, DC directional control